BBR Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
BBR Partners's RGEN Position: Q3 2021 in Review
BBR Partners sold out of Repligen (RGEN) in Q3 2021, closing a stake of 82,000 shares — an estimated $16.4M sold.
BBR Partners first reported a position in RGEN in Q3 2020 and held it in 4 quarters. The position peaked at $23.4M in Q1 2021. 478 funds tracked by Wall St. Rank hold RGEN as of Q3 2021.
- BBR Partners reported no remaining Repligen position as of Q3 2021 after selling out during the quarter.
- BBR Partners sold 82,000 Repligen shares in Q3 2021, an estimated $16.4M.
- BBR Partners first reported a position in Repligen in Q3 2020 and held it in 4 quarters.
- BBR Partners's Repligen position peaked at $23.4M in Q1 2021.
- 478 funds tracked by Wall St. Rank held Repligen as of Q3 2021.
Based on BBR Partners's 13F filing for Q3 2021, filed 12 Nov 2021.